Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy

Downs LO. et al, (2023), PLOS Global Public Health, 3, e0001165 - e0001165

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

Tomic A. et al, (2022), Nature Communications, 13

A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117

Zacharopoulou P. et al, (2022), Current Opinion in HIV and AIDS, 17, 352 - 358

Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study

Buch S. et al, (2022), Gut

Defining the key intrahepatic gene networks in HCV infection driven by sex

Marchi E. et al, (2022), Gut

Genotyping and population structure of the China Kadoorie Biobank

Walters RG. et al, (2022)

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy

Downs LO. et al, (2022)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Ogbe A. et al, (2022), JCI Insight, 7

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58

Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-stratification in Patients with Hepatitis C Cirrhosis.

Innes H. et al, (2022), Clinical and Translational Gastroenterology, Publish Ahead of Print

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

Angyal A. et al, (2022), The Lancet Microbe, 3, e21 - e31

The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis

Innes H. et al, (2021), Hepatology Communications

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus

Lin G-L. et al, (2021), Nature Communications, 12

Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection

Innes H. et al, (2021), JHEP Reports, 3, 100384 - 100384

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Ogbe A. et al, (2021), Nature Communications, 12

An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.

Adriano Vieira V. et al, (2021), PLoS pathogens, 17

Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure.

Smith DA. et al, (2021), Nature communications, 12

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Payne RP. et al, (2021), Cell

Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT

Cooke GS. et al, (2021), Efficacy and Mechanism Evaluation, 8, 1 - 90

Durability of ChAdOx1 nCov-19 (AZD1222) vaccination in people living with HIV - responses to SARS-CoV-2, variants of concern and circulating coronaviruses

Ogbe A. et al, (2021)

Load More

1
2
3
4
5

Include forthcoming?